Unknown

Dataset Information

0

Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit.


ABSTRACT: Electronic cigarettes (e-Cigs) are an attractive long-term alternative nicotine source to conventional cigarettes. Although they may assist smokers to remain abstinent during their quit attempt, studies using first generation e-Cigs report low success rates. Second generation devices (personal vaporisers - PVs) may result in much higher quit rates, but their efficacy and safety in smoking cessation and/or reduction in clinical trials is unreported.We conducted a prospective proof-of-concept study monitoring modifications in smoking behaviour of 50 smokers (unwilling to quit) switched onto PVs. Participants attended five study visits: baseline, week-4, week-8, week-12 and week-24. Number of cigarettes/day (cigs/day) and exhaled carbon monoxide (eCO) levels were noted at each visit. Smoking reduction/abstinence rates, product usage, adverse events and subjective opinions of these products were also reviewed.Sustained 50% and 80% reduction in cigs/day at week-24 was reported in 15/50 (30%) and 7/50 (14%) participants with a reduction from 25cigs/day to 6cigs/day (p?

SUBMITTER: Polosa R 

PROVIDER: S-EPMC4247211 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit.

Polosa Riccardo R   Caponnetto Pasquale P   Maglia Marilena M   Morjaria Jaymin B JB   Russo Cristina C  

BMC public health 20141108


<h4>Background</h4>Electronic cigarettes (e-Cigs) are an attractive long-term alternative nicotine source to conventional cigarettes. Although they may assist smokers to remain abstinent during their quit attempt, studies using first generation e-Cigs report low success rates. Second generation devices (personal vaporisers - PVs) may result in much higher quit rates, but their efficacy and safety in smoking cessation and/or reduction in clinical trials is unreported.<h4>Method</h4>We conducted a  ...[more]

Similar Datasets

| S-EPMC6037369 | biostudies-literature
| S-EPMC3372898 | biostudies-literature
| S-EPMC6277035 | biostudies-literature
| S-EPMC6478602 | biostudies-literature
| S-EPMC4772223 | biostudies-literature
| S-EPMC2896464 | biostudies-literature
| S-EPMC6334166 | biostudies-literature
| S-EPMC7115980 | biostudies-literature
| S-EPMC7443601 | biostudies-literature
| S-EPMC6141024 | biostudies-literature